• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哌嗪作为人碳酸酐酶I、II、IV和VII激活剂的研究。

Investigation of piperazines as human carbonic anhydrase I, II, IV and VII activators.

作者信息

Angeli Andrea, Chiaramonte Niccolò, Manetti Dina, Romanelli Maria Novella, Supuran Claudiu T

机构信息

a Dipartimento Neurofarba , Università degli Studi di Firenze, Sezione di Scienze Farmaceutiche e Nutraceutiche , Sesto Fiorentino (Florence) , Italy.

出版信息

J Enzyme Inhib Med Chem. 2018 Dec;33(1):303-308. doi: 10.1080/14756366.2017.1417277.

DOI:10.1080/14756366.2017.1417277
PMID:29280407
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6009915/
Abstract

Four human (h) carbonic anhydrase isoforms (CA, EC 4.2.1.1), hCA I, II, IV, and VII, were investigated for their activation profile with piperazines belonging to various classes, such as N-aryl-, N-alkyl-, N-acyl-piperazines as well as 2,4-disubstituted derivatives. As the activation mechanism involves participation of the activator in the proton shuttling between the zinc-coordinated water molecule and the external milieu, these derivatives possessing diverse basicity and different scaffolds were appropriate for being investigated as CA activators (CAAs). Most of these derivatives showed CA activating properties against hCA I, II, and VII (cytosolic isoforms) but were devoid of activity against the membrane-associated hCA IV. For hCA I, the Ks were in the range of 32.6-131 µM; for hCA II of 16.2-116 µM, and for hCA VII of 17.1-131 µM. The structure-activity relationship was intricate and not easy to rationalize, but the most effective activators were 1-(2-piperidinyl)-piperazine (K of 16.2 µM for hCA II), 2-benzyl-piperazine (K of 17.1 µM for hCA VII), and 1-(3-benzylpiperazin-1-yl)propan-1-one (K of 32.6 µM for hCA I). As CAAs may have interesting pharmacologic applications in cognition and for artificial tissue engineering, investigation of new classes of activators may be crucial for this relatively new research field.

摘要

研究了四种人类(h)碳酸酐酶同工型(CA,EC 4.2.1.1),即hCA I、II、IV和VII,与各类哌嗪的激活情况,这些哌嗪包括N-芳基-、N-烷基-、N-酰基-哌嗪以及2,4-二取代衍生物。由于激活机制涉及激活剂参与锌配位水分子与外部环境之间的质子穿梭,这些具有不同碱性和不同骨架的衍生物适合作为CA激活剂(CAA)进行研究。这些衍生物中的大多数对hCA I、II和VII(胞质同工型)表现出CA激活特性,但对膜相关的hCA IV没有活性。对于hCA I,Ks在32.6 - 131µM范围内;对于hCA II为16.2 - 116µM,对于hCA VII为17.1 - 131µM。构效关系复杂且难以合理化,但最有效的激活剂是1-(2-哌啶基)-哌嗪(hCA II的K为16.2µM)、2-苄基-哌嗪(hCA VII的K为17.1µM)和1-(3-苄基哌嗪-1-基)丙-1-酮(hCA I的K为32.6µM)。由于CAA在认知和人工组织工程方面可能具有有趣的药理学应用,研究新型激活剂对于这个相对较新的研究领域可能至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8878/6009915/af4816d406e7/IENZ_A_1417277_F0003_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8878/6009915/96a2d119eab5/IENZ_A_1417277_F0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8878/6009915/af4816d406e7/IENZ_A_1417277_F0003_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8878/6009915/96a2d119eab5/IENZ_A_1417277_F0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8878/6009915/af4816d406e7/IENZ_A_1417277_F0003_B.jpg

相似文献

1
Investigation of piperazines as human carbonic anhydrase I, II, IV and VII activators.哌嗪作为人碳酸酐酶I、II、IV和VII激活剂的研究。
J Enzyme Inhib Med Chem. 2018 Dec;33(1):303-308. doi: 10.1080/14756366.2017.1417277.
2
Carbonic anhydrase I, II, IV and IX inhibition with a series of 7-amino-3,4-dihydroquinolin-2(1H)-one derivatives.一系列7-氨基-3,4-二氢喹啉-2(1H)-酮衍生物对碳酸酐酶I、II、IV和IX的抑制作用
J Enzyme Inhib Med Chem. 2017 Dec;32(1):885-892. doi: 10.1080/14756366.2017.1337759.
3
Inhibition of human carbonic anhydrase isozymes I, II and VI with a series of bisphenol, methoxy and bromophenol compounds.一系列双酚、甲氧基和溴酚化合物对人碳酸酐酶同工酶 I、II 和 VI 的抑制作用。
J Enzyme Inhib Med Chem. 2012 Aug;27(4):467-75. doi: 10.3109/14756366.2011.596836. Epub 2011 Aug 4.
4
2-Benzylpiperazine: A new scaffold for potent human carbonic anhydrase inhibitors. Synthesis, enzyme inhibition, enantioselectivity, computational and crystallographic studies and in vivo activity for a new class of intraocular pressure lowering agents.2-苄基哌嗪:一种新型强效人碳酸酐酶抑制剂。合成、酶抑制、对映选择性、计算和晶体学研究以及一类新型降眼压药物的体内活性。
Eur J Med Chem. 2018 May 10;151:363-375. doi: 10.1016/j.ejmech.2018.04.002. Epub 2018 Apr 3.
5
Synthesis and biological evaluation of benzenesulphonamide-bearing 1,4,5-trisubstituted-1,2,3-triazoles possessing human carbonic anhydrase I, II, IV, and IX inhibitory activity.具有人碳酸酐酶I、II、IV和IX抑制活性的含苯磺酰胺基的1,4,5-三取代-1,2,3-三唑的合成及生物学评价
J Enzyme Inhib Med Chem. 2017 Dec;32(1):1187-1194. doi: 10.1080/14756366.2017.1367775.
6
Synthesis of novel 5-amino-1,3,4-thiadiazole-2-sulfonamide containing acridine sulfonamide/carboxamide compounds and investigation of their inhibition effects on human carbonic anhydrase I, II, IV and VII.合成含吖啶磺酰胺/酰胺的新型 5-氨基-1,3,4-噻二唑-2-磺酰胺化合物及其对人碳酸酐酶 I、II、IV 和 VII 的抑制作用研究。
Bioorg Chem. 2018 Apr;77:101-105. doi: 10.1016/j.bioorg.2017.12.035. Epub 2018 Jan 2.
7
Effects of dopaminergic compounds on carbonic anhydrase isozymes I, II, and VI.多巴胺化合物对碳酸酐酶同工酶 I、II 和 VI 的影响。
J Enzyme Inhib Med Chem. 2012 Jun;27(3):365-9. doi: 10.3109/14756366.2011.591290. Epub 2011 Jun 23.
8
Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies.新型基于吲哚啉-2-酮的磺酰胺类碳酸酐酶抑制剂:合成、针对碳酸酐酶同工酶I、II、IV和VII的体外生物学评价及分子对接研究
Eur J Med Chem. 2017 Feb 15;127:521-530. doi: 10.1016/j.ejmech.2017.01.017. Epub 2017 Jan 11.
9
Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isoforms I and II and transmembrane, tumor-associated isoforms IX and XII with boronic acids.碳酸酐酶抑制剂。硼酸对人胞质同工酶I和II以及跨膜、肿瘤相关同工酶IX和XII的抑制作用。
Bioorg Med Chem. 2009 May 15;17(10):3649-52. doi: 10.1016/j.bmc.2009.03.058. Epub 2009 Apr 5.
10
Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5- and 6-sulfonamides.一系列苯并[d]噻唑-5-和6-磺酰胺的合成及其对碳酸酐酶I、II、VII和IX的抑制研究
J Enzyme Inhib Med Chem. 2017 Dec;32(1):1071-1078. doi: 10.1080/14756366.2017.1356295.

引用本文的文献

1
Carbonic anhydrase activation profile of indole-based derivatives.吲哚类衍生物的碳酸酐酶激活特性。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1783-1797. doi: 10.1080/14756366.2021.1959573.
2
Effect of amino acids and amines on the activity of the recombinant ι-carbonic anhydrase from the Gram-negative bacterium .氨基酸和胺对革兰氏阴性菌重组 ι-碳酸酐酶活性的影响。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1000-1006. doi: 10.1080/14756366.2021.1919891.
3
Synthesis and Biological Evaluation of Imidazo[2 ,1-]Thiazole based Sulfonyl Piperazines as Novel Carbonic Anhydrase II Inhibitors.

本文引用的文献

1
Synthesis and biological evaluation of histamine Schiff bases as carbonic anhydrase I, II, IV, VII, and IX activators.组胺席夫碱作为碳酸酐酶I、II、IV、VII和IX激活剂的合成及生物学评价
J Enzyme Inhib Med Chem. 2017 Dec;32(1):1305-1312. doi: 10.1080/14756366.2017.1386660.
2
Psychoactive substances belonging to the amphetamine class potently activate brain carbonic anhydrase isoforms VA, VB, VII, and XII.属于苯丙胺类的精神活性物质能有效激活脑碳酸酐酶同工型VA、VB、VII和XII。
J Enzyme Inhib Med Chem. 2017 Dec;32(1):1253-1259. doi: 10.1080/14756366.2017.1375485.
3
Carbonic anhydrase activation enhances object recognition memory in mice through phosphorylation of the extracellular signal-regulated kinase in the cortex and the hippocampus.
基于咪唑并[2,1 - ]噻唑的磺酰基哌嗪类新型碳酸酐酶II抑制剂的合成与生物学评价
Metabolites. 2020 Mar 31;10(4):136. doi: 10.3390/metabo10040136.
4
Activation of human α-carbonic anhydrase isoforms I, II, IV and VII with bis-histamine schiff bases and bis-spinaceamine substituted derivatives.人源α-碳酸酐rase 同工酶 I、II、IV 和 VII 与双组氨酸席夫碱和双取代螺环胺衍生物的激活。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):1193-1198. doi: 10.1080/14756366.2019.1630616.
碳酸酐酶激活通过皮层和海马中细胞外信号调节激酶的磷酸化增强小鼠的物体识别记忆。
Neuropharmacology. 2017 May 15;118:148-156. doi: 10.1016/j.neuropharm.2017.03.009. Epub 2017 Mar 9.
4
A class of carbonic anhydrase I - selective activators.一类碳酸酐酶I选择性激活剂。
J Enzyme Inhib Med Chem. 2017 Dec;32(1):37-46. doi: 10.1080/14756366.2016.1232254. Epub 2016 Nov 1.
5
Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium.跨膜碳酸酐酶同工型IX和XII在炎症滑膜中的过表达。
J Enzyme Inhib Med Chem. 2016;31(sup4):60-63. doi: 10.1080/14756366.2016.1217857. Epub 2016 Aug 15.
6
Structure and function of carbonic anhydrases.碳酸酐酶的结构与功能。
Biochem J. 2016 Jul 15;473(14):2023-32. doi: 10.1042/BCJ20160115.
7
How many carbonic anhydrase inhibition mechanisms exist?存在多少种碳酸酐酶抑制机制?
J Enzyme Inhib Med Chem. 2016;31(3):345-60. doi: 10.3109/14756366.2015.1122001. Epub 2015 Nov 30.
8
Carbonic anhydrase inhibition for the management of cerebral ischemia: in vivo evaluation of sulfonamide and coumarin inhibitors.碳酸酐酶抑制在脑缺血管理中的应用:磺酰胺和香豆素抑制剂的体内评价。
J Enzyme Inhib Med Chem. 2016 Dec;31(6):894-9. doi: 10.3109/14756366.2015.1113407. Epub 2015 Nov 26.
9
Substituted piperazines as nootropic agents: 2- or 3-phenyl derivatives structurally related to the cognition-enhancer DM235.作为促智药的取代哌嗪:与认知增强剂DM235结构相关的2-或3-苯基衍生物。
Bioorg Med Chem Lett. 2015 Apr 15;25(8):1700-1704. doi: 10.1016/j.bmcl.2015.03.009. Epub 2015 Mar 12.
10
A class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects.一类具有调节神经性疼痛作用的磺酰胺类碳酸酐酶抑制剂。
Bioorg Med Chem. 2015 Apr 15;23(8):1828-40. doi: 10.1016/j.bmc.2015.02.027. Epub 2015 Feb 21.